AMBQ — Ambiq Micro, Inc.

AMBQ Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 2025 Performance:

  • Net sales reached $20.7 million, a 2% year-over-year increase and a 14.2% sequential increase.
  • Non-GAAP gross profit was $9.4 million, up 75.5%, with a gross margin of 45.5%, expanding nearly 20 percentage points year-over-year.
  • Non-GAAP net loss attributable to common stockholders was $5.9 million, improving from the previous year.
  • Cash and cash equivalents stood at $140.3 million post-IPO, with no debt.

• Full Year 2025 Highlights:

  • Achieved the highest-ever annual gross profit, with a 32.1% increase in gross profit dollars despite a 4.7% decrease in net sales.

2. Strategic Updates and Business Highlights

• Ambiq Micro experienced strong demand for its edge AI solutions, particularly with the adoption of the Apollo 5 platform.
• The company expanded its customer base, including a significant new wearable customer, and diversified its design funnel in sectors like medical, industrial, and smart home markets.
• Launched several new products, including Apollo 510 Lite, Apollo 510B, and Apollo 330, alongside the introduction of the Helia AOT and Helia RT AI runtime.
• A successful IPO demonstrated strong investor confidence, providing capital for growth initiatives.

3. Forward Guidance and Outlook

• For 2026, Ambiq Micro expects:
  • Net sales between $21 million and $22 million.
  • Non-GAAP gross margin between 44% and 45%.
  • Non-GAAP operating expenses projected at $18.0 million to $18.5 million, reflecting increased investment in R&D and strategic growth initiatives.
  • Non-GAAP loss per share anticipated to be between $0.39 and $0.33.
• Management expressed confidence in achieving over $100 million in revenue, driven by new model launches and ramping customer demand.

4. Bad News, Challenges, or Points of Concern

• Operating expenses are expected to increase significantly, with a $30 million rise compared to 2025, which may impact profitability.
• There are concerns about potential pressures on gross margins due to rising industry costs and component pricing, particularly in the latter half of 2026.
• The design cycles in regulated markets (medical and industrial) remain longer, which could delay revenue realization from new products.

5. Notable Q&A Insights

• Management indicated strong customer forecasts for 2026, with expectations for robust growth across all quarters, particularly in Q1 and Q2.
• The new customer ramping in 2026 is expected to contribute significantly to revenue, with growth anticipated to continue into 2027.
• There was discussion regarding the competitive advantage of Ambiq's 12-nanometer SPOT technology, which operates at lower voltages compared to standard offerings, providing a potential 4x energy efficiency advantage.
• The company is focused on maximizing value through high-revenue opportunities while managing costs effectively to maintain margins amidst rising industry pressures.

This summary encapsulates the key aspects of Ambiq Micro's Q4 2025 earnings call, highlighting financial performance, strategic initiatives, future outlook, and potential challenges.